Acenxion Biosystems: Funding, Investors & Team (Sep 2026)
Acenxion Biosystems is a company that is funded privately and focuses on creating automated systems for testing the susceptibility of microbes to antibiotics and detecting bacteria in blood samples. Their fAST system can be easily integrated into existing clinical practices and shortens the time needed for testing to 4-6 hours. This helps clinicians quickly identify the best treatment for patients, leading to better outcomes, lower healthcare expenses, and reduced antibiotic resistance. Ultimately, Acenxion's technology helps extend the effectiveness of antibiotics.
Acenxion Biosystems has raised $1.1M across 1 funding round on record, the most recent a Seed of $1.1M announced in Aug 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Acenxion Biosystems Company Profile and Key Stats
Latest funding round on record: Aug 2024.
Acenxion Biosystems Funding Rounds
Acenxion Biosystems Founders and Leadership Team
No contact details are on record for this team yet.
Acenxion Biosystems Funding Compared to Other Biotechnology Startups
Acenxion Biosystems' latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Acenxion Biosystems in Biotechnology and Kansas City
Companies Similar to Acenxion Biosystems
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Acenxion Biosystems Funding FAQs
What does Acenxion Biosystems do?
Acenxion Biosystems is a company that is funded privately and focuses on creating automated systems for testing the susceptibility of microbes to antibiotics and detecting bacteria in blood samples. Their fAST system can be easily integrated into existing clinical practices and shortens the time needed for testing to 4-6 hours. This helps clinicians quickly identify the best treatment for patients, leading to better outcomes, lower healthcare expenses, and reduced antibiotic resistance. Ultimately, Acenxion's technology helps extend the effectiveness of antibiotics.
How much funding has Acenxion Biosystems raised?
Acenxion Biosystems has raised $1.1M across 1 round on record. The most recent is a Seed of $1.1M announced in Aug 2024.
When did Acenxion Biosystems last raise funding?
Acenxion Biosystems' most recent funding round on record is a Seed of $1.1M, announced in Aug 2024.
Who founded Acenxion Biosystems?
FundedIQ lists Roy Swiger (Founder) at Acenxion Biosystems.
Where is Acenxion Biosystems headquartered?
Acenxion Biosystems is based in Kansas City, Kansas, United States.
How many employees does Acenxion Biosystems have?
Acenxion Biosystems is in the 1-10 employee band.
How does Acenxion Biosystems' funding compare to other Biotechnology startups?
Acenxion Biosystems' latest round of $1.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Acenxion Biosystems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Acenxion Biosystems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.